Mehta P, Campbell V, Maddox J, Floisand Y, et al. CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UK. Br J Haematol 2024;205:1326-1336.
PMID: 38977430